Visit-to-visit variability of blood pressure and risk of diabetic retinopathy: a systematic review and meta-analysis.

IF 1.3 American journal of cardiovascular disease Pub Date : 2024-10-15 eCollection Date: 2024-01-01 DOI:10.62347/DFSZ9202
Masoud Noroozi, Hamidreza Ghasemirad, Arshin Ghaedi, Meraj Kargar, Milad Alipour, Golnaz Mahmoudvand, Shirin Yaghoobpoor, Reza Taherinik, Gisou Erabi, Hamidreza Amiri, Kimia Keylani, Seyed Amirhossein Mazhari, Fatemeh Chichagi, Parisa Alsadat Dadkhah, Seyede Zohreh Mohagheghi, Akram Ansari, Zahra Sheikh, Niloofar Deravi
{"title":"Visit-to-visit variability of blood pressure and risk of diabetic retinopathy: a systematic review and meta-analysis.","authors":"Masoud Noroozi, Hamidreza Ghasemirad, Arshin Ghaedi, Meraj Kargar, Milad Alipour, Golnaz Mahmoudvand, Shirin Yaghoobpoor, Reza Taherinik, Gisou Erabi, Hamidreza Amiri, Kimia Keylani, Seyed Amirhossein Mazhari, Fatemeh Chichagi, Parisa Alsadat Dadkhah, Seyede Zohreh Mohagheghi, Akram Ansari, Zahra Sheikh, Niloofar Deravi","doi":"10.62347/DFSZ9202","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Diabetes mellitus (DM), a worldwide disease affecting more than 400 million people, is associated with high blood pressure (BP). In addition to macrovascular complications, high BP in DM patients is potentially linked to microvascular complications. More than 70% of DM patients have retinopathy. To our knowledge, no systematic review and meta-analysis has been conducted on the relationship between visit-to-visit variability in blood pressure and diabetic retinopathy risk.</p><p><strong>Methods: </strong>This systematic review and meta-analysis study was performed on the related articles. The search strategy, screening, and data selection were all checklist-based. A comprehensive search was done in three databases, including PubMed, Google Scholar, and Scopus. The Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) were followed. English clinical studies published up to January 2023 contained diabetic patients as the population, retinopathy as the outcome, and visit-to-visit blood pressure as the intervention. Using the QUIPS technique, two authors independently quantify the risk of bias in included publications. The meta-analysis was conducted using R version 4.4.1. We calculated relative risk (RR) as the effect size, applying the random effect model. Standard deviation (SD) and coefficient of variation (CV), were used as measures of BP variability.</p><p><strong>Results: </strong>A total number of 8 studies with 743,315 participants were covered in this systematic review. After meta-analysis, we concluded that the group with higher SD of BP variability had 2 percent higher risk than the control group (RR = 1.02, 95% CI = 1.01-1.03, I-squared = 41%); however, results of our analysis for CV of BP variability showed no significant contrast with control group thus no increased risk was reported (RR = 1.04, 95% CI = 0.94-1.15, I-squared = 32%, <i>P</i>-value = 0.23).</p><p><strong>Conclusion: </strong>In conclusion, an increased SD of BP variability significantly increased the relative risk for the development of retinopathy.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"14 5","pages":"281-294"},"PeriodicalIF":1.3000,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11578868/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of cardiovascular disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.62347/DFSZ9202","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Diabetes mellitus (DM), a worldwide disease affecting more than 400 million people, is associated with high blood pressure (BP). In addition to macrovascular complications, high BP in DM patients is potentially linked to microvascular complications. More than 70% of DM patients have retinopathy. To our knowledge, no systematic review and meta-analysis has been conducted on the relationship between visit-to-visit variability in blood pressure and diabetic retinopathy risk.

Methods: This systematic review and meta-analysis study was performed on the related articles. The search strategy, screening, and data selection were all checklist-based. A comprehensive search was done in three databases, including PubMed, Google Scholar, and Scopus. The Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) were followed. English clinical studies published up to January 2023 contained diabetic patients as the population, retinopathy as the outcome, and visit-to-visit blood pressure as the intervention. Using the QUIPS technique, two authors independently quantify the risk of bias in included publications. The meta-analysis was conducted using R version 4.4.1. We calculated relative risk (RR) as the effect size, applying the random effect model. Standard deviation (SD) and coefficient of variation (CV), were used as measures of BP variability.

Results: A total number of 8 studies with 743,315 participants were covered in this systematic review. After meta-analysis, we concluded that the group with higher SD of BP variability had 2 percent higher risk than the control group (RR = 1.02, 95% CI = 1.01-1.03, I-squared = 41%); however, results of our analysis for CV of BP variability showed no significant contrast with control group thus no increased risk was reported (RR = 1.04, 95% CI = 0.94-1.15, I-squared = 32%, P-value = 0.23).

Conclusion: In conclusion, an increased SD of BP variability significantly increased the relative risk for the development of retinopathy.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
血压的逐次变化与糖尿病视网膜病变的风险:系统回顾和荟萃分析。
背景:糖尿病(DM)是一种影响 4 亿多人的世界性疾病,与高血压(BP)有关。除大血管并发症外,糖尿病患者的高血压还可能与微血管并发症有关。超过 70% 的糖尿病患者患有视网膜病变。据我们所知,还没有人对血压的逐次变化与糖尿病视网膜病变风险之间的关系进行过系统回顾和荟萃分析:本系统综述和荟萃分析研究对相关文章进行了研究。检索策略、筛选和数据选择均以核对表为基础。在 PubMed、Google Scholar 和 Scopus 等三个数据库中进行了全面检索。检索遵循了系统综述和元分析的首选报告项目(PRISMA)。截至 2023 年 1 月发表的英文临床研究以糖尿病患者为研究对象,以视网膜病变为研究结果,以就诊血压为干预措施。两位作者使用 QUIPS 技术独立量化了纳入出版物的偏倚风险。荟萃分析使用 R 4.4.1 版本进行。我们采用随机效应模型计算相对风险(RR)作为效应大小。标准差(SD)和变异系数(CV)被用来衡量血压的变异性:本系统综述共涉及 8 项研究,743315 名参与者。经过荟萃分析,我们得出结论:血压变异性 SD 值较高的组别比对照组的风险高 2%(RR = 1.02,95% CI = 1.01-1.03,I 方 = 41%);然而,我们对血压变异性 CV 值的分析结果显示与对照组无明显对比,因此未报告风险增加(RR = 1.04,95% CI = 0.94-1.15,I 方 = 32%,P 值 = 0.23):总之,血压变异性的 SD 值增加会显著增加视网膜病变的相对风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
American journal of cardiovascular disease
American journal of cardiovascular disease CARDIAC & CARDIOVASCULAR SYSTEMS-
自引率
0.00%
发文量
21
期刊最新文献
Long-term outcomes following ultrathin vs thin-strut drug-eluting stents for percutaneous coronary intervention: an updated systematic review and meta-analysis of randomized control trials. Visit-to-visit variability of blood pressure and risk of diabetic retinopathy: a systematic review and meta-analysis. A diagnostic prediction model for the early detection of heart failure following primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. A normal and particularly small (<35 mm) left atrial size measured during echocardiography suggests low likelihood of moderate or severe left ventricular systolic dysfunction. Exploring the impact of metabolites function on heart failure and coronary heart disease: insights from a Mendelian randomization (MR) study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1